These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 6127626)

  • 21. The use of sulfasalazine in the treatment of inflammatory bowel disease.
    Spector R
    J Iowa Med Soc; 1983 Jun; 73(6):230-4. PubMed ID: 6135735
    [No Abstract]   [Full Text] [Related]  

  • 22. Inflammatory bowel disease: short- and long-term treatments.
    Bickston SJ; Cominelli F
    Dis Mon; 1998 Apr; 44(4):144-72. PubMed ID: 9580743
    [No Abstract]   [Full Text] [Related]  

  • 23. Chronic inflammatory bowel disease.
    Cavell B; Hildebrand H; Meeuwisse GW; Lindquist B
    Clin Gastroenterol; 1977 May; 6(2):481-96. PubMed ID: 18309
    [No Abstract]   [Full Text] [Related]  

  • 24. [Home parenteral nutrition in pediatric patients].
    Hirokawa K; Iwafuchi M
    Nihon Rinsho; 1991 Nov; 49 Suppl():737-41. PubMed ID: 1798189
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunopathology of ulcerative colitis and Crohn's disease, nonsurgical therapeutic considerations.
    Bläker F; Schäfer KH
    Eur J Pediatr; 1982 Nov; 139(3):162-4. PubMed ID: 6130950
    [No Abstract]   [Full Text] [Related]  

  • 26. [Importance of intravenous hyperalimentation in the pre- and post-operative treatment of patients with intestinal inflammatory diseases].
    Trabucchi E; Zennaro F; Baratti C; Colombo R; Rosina Ferla M
    Minerva Chir; 1983 Oct; 38(20):1695-7. PubMed ID: 6420727
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in therapy of ulcerative colitis and Crohn disease].
    Farthmann EH; Gerok W
    Fortschr Med; 1991 Apr; 109(11):231. PubMed ID: 1855747
    [No Abstract]   [Full Text] [Related]  

  • 28. Psychological management of Crohn's disease.
    Paulley JW
    Practitioner; 1974 Jul; 213(1273):59-64. PubMed ID: 4155498
    [No Abstract]   [Full Text] [Related]  

  • 29. [Inflammatory bowel diseases in children].
    Dupont C
    Ann Gastroenterol Hepatol (Paris); 1995 Sep; 31(4):237-53. PubMed ID: 7486821
    [No Abstract]   [Full Text] [Related]  

  • 30. Medical treatment of ulcerative colitis and Crohn's disease.
    Rhodes JM
    J Clin Hosp Pharm; 1983 Sep; 8(3):219-32. PubMed ID: 6138368
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic principles for chronic inflammatory bowel disease].
    Binder V; Munkholm P
    Ugeskr Laeger; 2001 Jan; 163(1):16-21. PubMed ID: 11586666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Exacerbation of ulcerative colitis and Crohn disease as a phenomenon inherent in the disease].
    Habs M; Schifmann R
    Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1131. PubMed ID: 2874004
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug information. Pentasa--new Danish drug].
    Dahlerup J
    Sygeplejersken; 1988 Jul; 88(28):16. PubMed ID: 2902698
    [No Abstract]   [Full Text] [Related]  

  • 34. [Rational treatment of ulcerative colitis and Crohn's disease].
    Vucelić B
    Lijec Vjesn; 1982 Jun; 104(6):256-9. PubMed ID: 7144414
    [No Abstract]   [Full Text] [Related]  

  • 35. [40 years of salazosulfapyridine. Is end in sight?].
    van Hees PA; van Tongeren JH
    Ned Tijdschr Geneeskd; 1982 Oct; 126(44):2014-8. PubMed ID: 6129576
    [No Abstract]   [Full Text] [Related]  

  • 36. [Management of the chronically ill patient with Crohn disease and ulcerative colitis].
    Goebell H
    Zentralbl Chir; 1998; 123 Suppl():40-4. PubMed ID: 9586171
    [No Abstract]   [Full Text] [Related]  

  • 37. [Crohn's disease and ulcerative colitis].
    Dray X; Marteau P
    Rev Prat; 2007 Dec; 57(20):2305-10. PubMed ID: 18320754
    [No Abstract]   [Full Text] [Related]  

  • 38. Chronic inflammatory bowel disease in the young.
    Chong SK; Walker-Smith JA
    Compr Ther; 1982 Oct; 8(10):27-34. PubMed ID: 7140201
    [No Abstract]   [Full Text] [Related]  

  • 39. [Possible mechanism of action of Azulfidine/Salazopyrin].
    Campbell DE
    Z Gastroenterol Verh; 1981 Jun; 19():15-20. PubMed ID: 6168126
    [No Abstract]   [Full Text] [Related]  

  • 40. [When should parenteral feeding and elemental diets be employed for intestinal inflammations?].
    Riecken EO
    Internist (Berl); 1978 Dec; 19(12):687-91. PubMed ID: 106019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.